Financials
Financial year 2025
Worth noting
- Little cash and receivables against the short-term debts.
Revenue
€ 2.1 million
▲ 10% vs 2024
Profit
Healthy€ 4.3 million
▼ 41% vs 2024
Debts
Low€ 3.8 million
▼ 7% vs 2024
PHARMA FLEX from Nivelles, company number BE0897187147, closed financial year 2025 with a result of € 4.3 million after tax. For that financial year PHARMA FLEX recorded revenue of € 2.1 million and equity of € 10.5 million. Compared with financial year 2024, the result moved from € 7.4 million to € 4.3 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 27, 2026.
What happened at PHARMA FLEX?
What happened at PHARMA FLEX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- AdFinitis Srl stepped down as director. NBB
- NextGen Invest Srl stepped down as director. NBB
- AdFines Srl stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 4.3 million (▼ 41% vs 2024). Source: NBB ↗
- AdFinitis Srl became a director. NBB
- NextGen Invest Srl became a director. NBB
- AdFines Srl became a director. NBB
- Martial Dollinger became a director. NBB
In short
From € 4.6 million profit in 2021 to € 4.3 million profit in 2025.
Paid € 493,564 in corporate taxes since 2021.
Best year ever: 2024, with € 7.4 million profit.
Paid out € 27.5 million in dividends to the owners in total.
A new publication or filing at PHARMA FLEX? We notify you, reason included.
Follow PHARMA FLEXNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind PHARMA FLEX is Martial Dollinger. It owns 100% of PHARMA TECHNOLOGY INC, 100% of PHARMA TECHNOLOGY - PHARMA FLEX GMBH, 100% of PHARMA TECHNOLOGY ASIA PACIFIC LTD and 100% of PHARMA TECHNOLOGY itself.
Directors
According to the 2025 annual accounts
since 2020
Director · represented by Martial Dollinger
Also active at: DOLFINANCE, DOLLIMMO BELGIUM
since 2024 · until 2030
since 2024 · until 2030
since 2024 · until 2030
Establishments
Establishment units
Physical locations of this company
Rue Graham Bell 8
1402 Nivelles
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
PHARMA TECHNOLOGY same network
€ 26.8 million revenue · 2025
DOLFINANCE same network
€ 116,272 gross margin · 2025
PHARMA VAT UNIT
DOLLIMMO BELGIUM same network
€ -28,846 gross margin · 2025
NextGen Invest same network
€ 123,127 gross margin · 2025
+1 more
Details
- Company number
- 0897.187.147
- VAT number
- BE 0897.187.147
- Registered office
- Rue Graham Bell 8, 1402 Nivelles
- Names & denominations
- PHARMA FLEX
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 4 April 2008
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Vervaardiging van overige machines en apparaten voor algemeen gebruik, neg
Vervaardiging van andere machines voor specifieke doeleinden neg
Handelsbemiddeling in de groothandel in andere specifieke goederen